SCP1-IN-1

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

SCP1-IN-1 (compoundSH T-62) 是一种针对 SCP1 的强效选择性共价抑制剂。SCP1-IN-1 促进 REST 降解并降低转录活性。高水平的 REST 蛋白驱动一些胶质母细胞瘤细胞的肿瘤生长。SCP1-IN-1 具有研究由 REST 转录活动驱动生长的胶质母细胞瘤的潜力。

SCP1-IN-1 (compoundSH T-62) is a potent and selective covalent inhibitor against SCP1. SCP1-IN-1 promotes REST degradation and reduces transcriptional activity. A high level of REST protein drives the tumor growth in some glioblastoma cells. SCP1-IN-1 has the potential for the research of glioblastoma whose growth is driven by REST transcription activity.

——

——

——

Others

Other Targets

Others

——

——

2764615-55-4

520.5

C20H19F3N2O7S2

>98% (HPLC)

In Vitro:?DMSO 中的溶解度 : 100 mg/mL (192.12 mM; 超声助溶 )

FC(F)(F)Oc1ccc(cc1)S(=O)(=O)NCCOCCNC(=O)C1=Cc2ccccc2S1(=O)=O

——

(-20℃)

With Ice Pack

≥ 2 years